Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T11:22:53.234Z Has data issue: false hasContentIssue false
  • English
  • Français

Thyroid Hormone Supplementation of Fluoxetine in the Treatment of Major Depression

Published online by Cambridge University Press:  02 January 2018

Sanjay Gupta ,
Prakash Masand  and
John F. Tanquary
Sanjay Gupta*
Affiliation:
State University of New York Health Science Center at Syracuse, 750 E. Adams Street, Syracuse, New York 13210
Prakash Masand
Affiliation:
State University of New York Health Science Center at Syracuse
John F. Tanquary
Affiliation:
State University of New York Health Science Center at Syracuse, New York 13210
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

A patient with major depression who did not respond to treatment with fluoxetine alone responded to thyroid hormone augmentation of fluoxetine.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 159 , Issue 6 , December 1991 , pp. 866 - 867
Copyright
Copyright © 1991 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Byerley, W. F., McConnell, E. J. & Mccabe, R. T. (1988) Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine. Psychopharmacology (Berlin), 94, 141–143.CrossRefGoogle ScholarPubMed
Crow, D., Collins, J. P. & Rosse, R. B. (1990) Thyroid hormone supplementation of fluoxetine treatment. Journal of Clinical Psychopharmacology, 10, 150–151.CrossRefGoogle Scholar
Elkin, I., Shea, M. T., Watkins, J. T., et al (1989) National Institute of Mental Health. Treatment of depression collaborative research program. Archives of General Psychiatry, 46, 971–983.CrossRefGoogle ScholarPubMed
Extein, I. L. & Gold, M. S. (1988) Thyroid hormone potentiation of tricyclics. Psychosomatics, 29, 166–174.CrossRefGoogle ScholarPubMed
Gitlin, M. J., Weiner, H. & Fairbanks, L. (1986). Failure of T3 to potentiate tricyclic response. In Program and Papers on New Research, 139th Annual Meeting of the American Psychiatric Association (p. 107). Washington, DC: American Psychiatric Association.Google Scholar
Goodwin, F. K., Prange, A. J. Jr, Post, R. M., et al (1982) Potentiation of antidepressant effects by L-triiodothyronine in tricyclic non-responders. American Journal of Psychiatry, 139, 34–38.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle ScholarPubMed
Heninger, G. R., Charney, D. S. & Sternberg, D. E. (1983) Lithium carbonate augmentation of antidepressant treatment: An effective prescription for treatment refractory depression. Archives of General Psychiatry, 40, 1335–1342.CrossRefGoogle ScholarPubMed
Pope, H., McElroy, S. & Nixon, R. (1988) Possible synergism between fluoxetine and lithium carbonate in refractory depression. American Journal of Psychiatry, 45, 1292–1294.Google Scholar
Wheatley, D. (1970) Potentiation of amitriptyline by thyroid hormone. Archives of General Psychiatry, 26, 229–233.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.